[1]
K. M B, G. J Sh, and L. E E, “COST-EFFECTIVENESS OF HLA-B*5701 PROSPECTIVE GENETIC SCREENING OF HYPERSENSITIVITY TO ABACAVIR”, Asian J Pharm Clin Res, vol. 11, no. 2, pp. 281–283, Feb. 2018.